4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-050770
Chief Technology Officer sold 20,000 shares at $12.42 ($248,400)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-09-19 | Sale | −20,000 | $12.42 | $248,400 | 8,025,624 | D |
| Open-market sales · 20,000 sh · avg $12.42 · $248,400 | |||||||
Loading xslF345X03/doc4.xml…